A. Huart

发表

Increased ischemic stroke, acute coronary artery disease and mortality in patients with granulomatosis with polyangiitis and microscopic polyangiitis.

J. Ruidavets, Y. Béjot, D. Chauveau, 2019, Journal of autoimmunity.

The Effectiveness of Topical Cerium Nitrate-Silver Sulfadiazine Application on Overall Outcome in Patients with Calciphylaxis

D. Chauveau, N. Kamar, S. Faguer, 2019, Dermatology.

Kinin B1 receptor antagonism is equally efficient as angiotensin receptor 1 antagonism in reducing renal fibrosis in experimental obstructive nephropathy, but is not additive

J. Schanstra, J. Klein, J. Bascands, 2015, Front. Pharmacol..

UMOD genetic variations and myeloma cast nephropathy

N. Chassaing, D. Chauveau, J. Belliere, 2019, Clinical kidney journal.

Plasma exchange and thrombotic microangiopathies: From pathophysiology to clinical practice.

D. Chauveau, S. Faguer, D. Ribes, 2020, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

Zoster after Cyclophosphamide for Systemic Lupus Erythematosus or Vasculitis: Incidence, Risk Factors, and Effect of Antiviral Prophylaxis

C. Mengelle, H. Derumeaux, D. Chauveau, 2018, The Journal of Rheumatology.

Weaning of maintenance immunosuppressive therapy in lupus nephritis (WIN-Lupus): results of a multicentre randomised controlled trial

K. Baumstarck, A. Loundou, L. Chiche, 2022, Annals of the Rheumatic Diseases.

Kidney Involvement in Patients With Chronic Myelomonocytic Leukemia or BCR-ABL–Negative Myeloproliferative Neoplasms

D. Chauveau, C. Récher, I. Luquet, 2020, Kidney international reports.

IgA-mediated anti-glomerular basement membrane disease: an uncommon mechanism of Goodpasture's syndrome

D. Chauveau, G. Moulis, A. Huart, 2012, Clinical kidney journal.

Tocilizumab added to conventional therapy reverses both the cytokine profile and CD8+Granzyme+ T‐cells/NK cells expansion in refractory hemophagocytic lymphohistiocytosis

L. Rostaing, M. Nogier, G. Prévot, 2016, Hematological oncology.

Sine scleroderma, limited cutaneous, and diffused cutaneous systemic sclerosis survival and predictors of mortality

G. Prévot, L. Astudillo, L. Sailler, 2021, Arthritis Research & Therapy.

Prognostic factors of survival in patients with non-infectious mixed cryoglobulinaemia vasculitis: data from 242 cases included in the CryoVas survey

F. Carrat, X. Mariette, O. Hermine, 2012, Annals of the rheumatic diseases.

Reducing the initial number of rituximab maintenance-therapy infusions for ANCA-associated vasculitides: randomized-trial post-hoc analysis.

B. Bonnotte, L. Mouthon, F. Maurier, 2020, Rheumatology.

Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2)

P. Ravaud, B. Bonnotte, L. Mouthon, 2018, Annals of the rheumatic diseases.

Gateway and journey of patients with cardiac amyloidosis

P. Cintas, D. Carrié, M. Galinier, 2020, ESC heart failure.

New Oral Anticoagulants vs. Vitamin K Antagonists Among Patients With Cardiac Amyloidosis: Prognostic Impact

P. Cintas, D. Carrié, M. Galinier, 2021, Frontiers in Cardiovascular Medicine.

Pattern of myocardial 99mTc-HMDP uptake and impact on myocardial function in patients with transthyretin cardiac amyloidosis

D. Chauveau, G. Prévot, P. Cintas, 2018, Journal of Nuclear Cardiology.

Hepatocyte Nuclear Factor-1β Controls Mitochondrial Respiration in Renal Tubular Cells.

N. Chassaing, J. Schanstra, M. Pontoglio, 2017, Journal of the American Society of Nephrology : JASN.

Role of C5 inhibition in Idiopathic Inflammatory Myopathies and Scleroderma Renal Crisis–Induced Thrombotic Microangiopathies

D. Chauveau, G. Prévot, J. Belliere, 2021, Kidney international reports.

Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis.

M. Beksac, M. Dimopoulos, Kihyun Kim, 2021, The New England journal of medicine.

Spectrum and Prognosis of Noninfectious Renal Mixed Cryoglobulinemic GN.

N. Rioux-Leclercq, F. Carrat, X. Mariette, 2016, Journal of the American Society of Nephrology : JASN.

The spectrum of renal involvement in male patients with infertility related to excretory-system abnormalities: phenotypes, genotypes, and genetic counseling

P. Calvas, N. Chassaing, D. Chauveau, 2017, Journal of Nephrology.

Acquired factor VIII haemophilia following influenza vaccination

J. Montastruc, D. Chauveau, G. Moulis, 2010, European Journal of Clinical Pharmacology.

Predictors of early relapse in patients with non-infectious mixed cryoglobulinemia vasculitis: results from the French nationwide CryoVas survey.

F. Carrat, X. Mariette, E. Lazaro, 2014, Autoimmunity reviews.

Population pharmacokinetics of rituximab with or without plasmapheresis in kidney patients with antibody-mediated disease.

L. Rostaing, N. Kamar, M. White-Koning, 2013, British journal of clinical pharmacology.

Rituximab–cyclophosphamide‐dexamethasone is highly effective in patients with monoclonal Ig deposit‐related glomerulopathy and indolent non‐Hodgkin lymphomas

D. Chauveau, L. Obéric, L. Ysebaert, 2014, American journal of hematology.

Renal and overall outcomes of double-positive (ANCA and anti-GBM antibodies) patients compared to ANCA-associated vasculitis patients with severe renal involvement: A multicenter retrospective study with systematic renal pathology analysis

E. Thervet, X. Puéchal, A. Karras, 2021, Scandinavian Journal of Rheumatology.

Long-Term Rituximab Use to Maintain Remission of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis

P. Ravaud, B. Bonnotte, L. Mouthon, 2020, Annals of Internal Medicine.

Spectrum of Kidney Disorders Associated with T-Cell Immunoclones

D. Chauveau, L. Obéric, L. Ysebaert, 2022, Journal of clinical medicine.

Cryofibrinogenemia: a marker of severity of cryoglobulinemic vasculitis.

A. Blancher, B. Puissant, G. Moulis, 2015, The American journal of medicine.

The factor VIII:C/VWF:Ag ratio as a useful tool to predict relapse in patients with acquired haemophilia A: A retrospective cohort study

M. Béné, D. Chauveau, A. Néel, 2019, Haemophilia : the official journal of the World Federation of Hemophilia.

Outcomes of patients with Goodpasture syndrome: A nationwide cohort-based study from the French Society of Hemapheresis.

D. Chauveau, N. Kamar, J. Pourrat, 2016, Journal of autoimmunity.

Renal side effects of adefovir in hepatitis B virus-(HBV) positive kidney allograft recipients.

L. Rostaing, J. Izopet, N. Kamar, 2009, Clinical nephrology.

The HNF1B score is a simple tool to select patients for HNF1B gene analysis.

P. Calvas, N. Chassaing, J. Schanstra, 2014, Kidney international.

Plasma exchanges for the treatment of severe systemic necrotizing vasculitides in clinical daily practice: Data from the French Vasculitis Study Group.

D. Chauveau, L. Mouthon, J. Aniort, 2015, Journal of autoimmunity.

Avacopan as First-Line Treatment in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Steroid-Sparing Option

J. Schanstra, D. Chauveau, J. Belliere, 2022, Kidney international reports.

[An unusual retroperitoneal tumor].

C. Guilbeau-Frugier, A. Gomez-Brouchet, J. Pourrat, 2010, Annales de pathologie.

Bendamustine plus rituximab for indolent B‐cell lymphoma of renal significance

D. Chauveau, L. Obéric, L. Ysebaert, 2018, American journal of hematology.

Management of noninfectious mixed cryoglobulinemia vasculitis: data from 242 cases included in the CryoVas survey.

F. Carrat, X. Mariette, E. Lazaro, 2012, Blood.

Alternative complement pathway hemolytic assays reveal incomplete complement blockade in patients treated with eculizumab.

D. Chauveau, A. Blancher, N. Kamar, 2017, Clinical immunology.

Short‐ and long‐term outcomes of AL amyloidosis patients admitted into intensive care units

D. Chauveau, M. Nogier, É. Azoulay, 2016, British journal of haematology.

A prospective phase II of daratumumab in previously treated systemic light chain amyloidosis (AL) patients.

S. Chevret, P. Morel, M. Macro, 2020, Blood.

A Prospective Phase II of Daratumumab in Previously-Treated Systemic Light-Chain (AL) Amyloidosis

P. Morel, M. Macro, L. Frenzel, 2017 .

Pretransplant urinary proteome analysis does not predict development of chronic kidney disease after liver transplantation

J. Schanstra, P. Moulos, L. Rostaing, 2015, Liver international : official journal of the International Association for the Study of the Liver.

Atrial fibrillation and subtype of atrial fibrillation in cardiac amyloidosis: clinical and echocardiographic features, impact on mortality

P. Cintas, D. Carrié, M. Galinier, 2019, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

Pilot study for left ventricular imaging phenotype of patients over 65 years old with heart failure and preserved ejection fraction: the high prevalence of amyloid cardiomyopathy

H. Rousseau, D. Chauveau, D. Carrié, 2016, The International Journal of Cardiovascular Imaging.

Outcomes of Older Patients (≥60 years) with New-Onset Idiopathic Nephrotic Syndrome Receiving Immunosuppressive Regimen: A Multicentre Study of 116 Patients

E. Daugas, D. Chauveau, J. Boffa, 2019, Journal of clinical medicine.

L. Arnaud, H. François, A. Kettaneh, 2007, Clinical nephrology.

Value of natriuretic peptides and tissue Doppler imaging in the estimation of left ventricular filling pressure in patients with cardiac amyloidosis

D. Carrié, M. Galinier, O. Lairez, 2019, Open Heart.

[Cryofibrinogenemia: a single-center study at the University Hospital of Toulouse, France].

A. Blancher, B. Puissant, G. Moulis, 2015, La Revue de medecine interne.

Real-world study of the efficacy and safety of belantamab mafodotin (GSK2857916) in relapsed or refractory multiple myeloma based on data from the nominative ATU in France: IFM 2020-04 study.

O. Decaux, P. Moreau, H. Avet-Loiseau, 2023, Haematologica.

L. Rostaing, N. Kamar, D. Durand, 2006, Clinical nephrology.